Real Brokerage unveils the post-merger board and supplements its proxy amid shareholder lawsuits ahead of the RE/MAX vote
REAX is trading near its 52-week low of $1.55 (11% above the low).
Summary
Real Brokerage named the post-merger board for its RE/MAX acquisition and supplemented its proxy with new financial details after stockholders sued, alleging inadequate disclosures. The shareholder vote is set for August 14.
Key Events · M&A and Partnerships · REAX
-
Post-Merger Board Announced
Real disclosed the 10 directors expected to lead Real REMAX Group after the RE/MAX acquisition closes, including CEO Tamir Poleg as Chair, RE/MAX CEO Erik Carlson, and eight independent directors from both companies.
-
Proxy Supplemented After Lawsuits
In response to stockholder demand letters and two New York lawsuits alleging misleading disclosures, Real voluntarily added new financial analysis details to the joint proxy, including FV/2026E EBITDA multiples (Real: 20.5x, RE/MAX: 6.1x) and DCF terminal multiples (8.0x–9.4x for RE/MAX, 16.3x–20.7x for Real).
-
Litigation Risk Disclosed
The filing reveals that RE/MAX stockholders filed complaints on July 22 and 23, 2026, seeking to enjoin the merger or obtain damages, alleging the proxy omitted material information about financial projections and J.P. Morgan's analyses.
-
Shareholder Vote Imminent
The special meetings for Real securityholders and RE/MAX stockholders remain scheduled for August 14, 2026, with the merger expected to close in the second half of 2026, subject to approvals.
Analysis · REAX · Real Estate & Construction
With the shareholder vote on the $880 million RE/MAX acquisition just eight days away, Real Brokerage disclosed the 10-member board that will lead the combined company, blending directors from both firms. The filing also reveals that RE/MAX stockholders have sent demand letters and filed two lawsuits alleging the proxy omitted material details about financial projections and the deal's background. To avoid delays, Real voluntarily added new financial analysis data — including specific EBITDA multiples and DCF terminal multiples — to the proxy. This preemptive move aims to neutralize litigation risk and keep the merger on track, but the lawsuits introduce uncertainty around the August 14 vote.
At the time of this filing, REAX was trading at $1.72 on NASDAQ in the Real Estate & Construction sector, with a market capitalization of approximately $379.2M. The 52-week trading range was $1.55 to $5.41. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.